AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 1-25/216
TRAUMA AND THERMAL-INJURY - COMPARISON OF HEMOSTATIC AND CYTOKINE CHANGES IN THE ACUTE-PHASE OF INJURY
Authors: KOWALVERN A SHARPPUCCI MM WALENGA JM DRIES DJ GAMELLI RL
Citation: A. Kowalvern et al., TRAUMA AND THERMAL-INJURY - COMPARISON OF HEMOSTATIC AND CYTOKINE CHANGES IN THE ACUTE-PHASE OF INJURY, The journal of trauma, injury, infection, and critical care, 44(2), 1998, pp. 325-329
MOLECULAR MARKERS OF HEMOSTATIC ACTIVATION AND INFLAMMATION FOLLOWINGMAJOR INJURY - EFFECT OF THERAPY WITH IFN-GAMMA
Authors: DRIES DJ WALENGA JM HOPPENSTEADT D FAREED J
Citation: Dj. Dries et al., MOLECULAR MARKERS OF HEMOSTATIC ACTIVATION AND INFLAMMATION FOLLOWINGMAJOR INJURY - EFFECT OF THERAPY WITH IFN-GAMMA, Journal of interferon & cytokine research, 18(5), 1998, pp. 327-335
PHARMACOKINETICS AND PHARMACODYNAMICS OF ARGATROBAN AS STUDIED BY HPLC AND FUNCTIONAL METHODS - IMPLICATIONS IN THE MONITORING AND DOSAGE-OPTIMIZATIONS IN CARDIOVASCULAR PATIENTS
Authors: AHMAD S AHSAN A IQBAL O HOPPENSTEADT DA LEWIS BE WALENGA JM FAREED J
Citation: S. Ahmad et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF ARGATROBAN AS STUDIED BY HPLC AND FUNCTIONAL METHODS - IMPLICATIONS IN THE MONITORING AND DOSAGE-OPTIMIZATIONS IN CARDIOVASCULAR PATIENTS, Clinical and applied thrombosis/hemostasis, 4(4), 1998, pp. 243-249
COMPARATIVE ANALYSES OF CIRCULATING ARGATROBAN LEVELS IN HIT PATIENTSUTILIZING HPLC AND ECT METHODS
Authors: ASHAN A IQBAL O AHMAD S ANGELATS RS WALENGA JM FAREED J
Citation: A. Ashan et al., COMPARATIVE ANALYSES OF CIRCULATING ARGATROBAN LEVELS IN HIT PATIENTSUTILIZING HPLC AND ECT METHODS, The FASEB journal, 12(5), 1998, pp. 4183-4183
QUANTITATION OF SOLUBLE P-SELECTIN IN HUMAN PLASMA - EFFECT OF ANTICOAGULANT MATRIX AND PRELIMINARY CLINICAL-DATA
Authors: AMIN HM LIETZ H HOPPENSTEADT DA WALENGA JM GEORGE M AHMAD S FAREED J
Citation: Hm. Amin et al., QUANTITATION OF SOLUBLE P-SELECTIN IN HUMAN PLASMA - EFFECT OF ANTICOAGULANT MATRIX AND PRELIMINARY CLINICAL-DATA, The FASEB journal, 12(4), 1998, pp. 1115-1115
PHARMACOKINETICS AND PHARMACODYNAMICS OF A SYNTHETIC ANTITHROMBIN AGENT, ARGATROBAN, IN MAN AS STUDIED BY HPLC AND FUNCTIONAL METHODS - IMPLICATIONS IN THE MONITORING AND DOSAGE-OPTIMIZATIONS IN CARDIOVASCULARPATIENTS
Authors: AHMAD S AHSAN A IQBAL O HOPPENSTEADT DA LEWIS BE WALENGA JM FAREED J
Citation: S. Ahmad et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF A SYNTHETIC ANTITHROMBIN AGENT, ARGATROBAN, IN MAN AS STUDIED BY HPLC AND FUNCTIONAL METHODS - IMPLICATIONS IN THE MONITORING AND DOSAGE-OPTIMIZATIONS IN CARDIOVASCULARPATIENTS, The FASEB journal, 12(4), 1998, pp. 2368-2368
TISSUE FACTOR PATHWAY INHIBITOR RELEASE IS SPECIFIC FOR HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARINS - IMPLICATIONS IN THE MANAGEMENT OF CORONARY SYNDROMES
Authors: HOPPENSTEADT D FAREED J AMIRAL J JESKE W WALENGA JM LEWIS B WELZEL D
Citation: D. Hoppensteadt et al., TISSUE FACTOR PATHWAY INHIBITOR RELEASE IS SPECIFIC FOR HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARINS - IMPLICATIONS IN THE MANAGEMENT OF CORONARY SYNDROMES, Journal of the American College of Cardiology, 31(2), 1998, pp. 53-53
EFFECT OF SR121566A, A POTENT GP IIB-IIIA ANTAGONIST, ON THE HIT SERUM HEPARIN-INDUCED PLATELET-MEDIATED ACTIVATION OF HUMAN ENDOTHELIAL-CELLS
Authors: HERBERT JM SAVI P JESKE WP WALENGA JM
Citation: Jm. Herbert et al., EFFECT OF SR121566A, A POTENT GP IIB-IIIA ANTAGONIST, ON THE HIT SERUM HEPARIN-INDUCED PLATELET-MEDIATED ACTIVATION OF HUMAN ENDOTHELIAL-CELLS, Thrombosis and haemostasis, 80(2), 1998, pp. 326-331
ETHYLENEDIAMINETETRAACETIC ACID (EDTA) IN HEPARIN
Authors: COYNE E MESSMORE HL WALENGA JM FAREED J WEHRMACHER WH
Citation: E. Coyne et al., ETHYLENEDIAMINETETRAACETIC ACID (EDTA) IN HEPARIN, Thrombosis research, 90(5), 1998, pp. 245-246
TISSUE FACTOR PATHWAY INHIBITOR (TFPI) HAS STRONG ANTICOAGULANT AND ANTITHROMBOTIC ACTIONS IN-VITRO AND IN-VIVO
Authors: KAISER B HOPPENSTEAD DH WALENGA JM GLUSA E FAREED J
Citation: B. Kaiser et al., TISSUE FACTOR PATHWAY INHIBITOR (TFPI) HAS STRONG ANTICOAGULANT AND ANTITHROMBOTIC ACTIONS IN-VITRO AND IN-VIVO, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 426-426
THROMBIN GENERATION IN WHOLE-BLOOD IS EFFECTIVELY INHIBITED BY FACTORXA BUT NOT BY THROMBIN INHIBITORS
Authors: KAISER B WALENGA JM GLUSA E FAREED J
Citation: B. Kaiser et al., THROMBIN GENERATION IN WHOLE-BLOOD IS EFFECTIVELY INHIBITED BY FACTORXA BUT NOT BY THROMBIN INHIBITORS, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 427-427
ANTITHROMBOTIC EFFECTS OF FACTOR XA AND THROMBIN INHIBITORS IN A MODEL OF ENDOVASCULAR INJURY IN RABBITS
Authors: KAISER B GLUSA E WALENGA JM FAREED J
Citation: B. Kaiser et al., ANTITHROMBOTIC EFFECTS OF FACTOR XA AND THROMBIN INHIBITORS IN A MODEL OF ENDOVASCULAR INJURY IN RABBITS, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 458-458
ANTITHROMBIN AGENTS AS ANTICOAGULANTS AND ANTITHROMBOTICS - IMPLICATIONS IN DRUG DEVELOPMENT
Authors: FAREED J CALLAS D HOPPENSTEADT DA WALENGA JM BICK RL
Citation: J. Fareed et al., ANTITHROMBIN AGENTS AS ANTICOAGULANTS AND ANTITHROMBOTICS - IMPLICATIONS IN DRUG DEVELOPMENT, The Medical clinics of North America, 82(3), 1998, pp. 569
HEPARIN-INDUCED THROMBOCYTOPENIA, PARADOXICAL THROMBOEMBOLISM, AND OTHER SIDE-EFFECTS OF HEPARIN-THERAPY
Authors: WALENGA JM BICK RL
Citation: Jm. Walenga et Rl. Bick, HEPARIN-INDUCED THROMBOCYTOPENIA, PARADOXICAL THROMBOEMBOLISM, AND OTHER SIDE-EFFECTS OF HEPARIN-THERAPY, The Medical clinics of North America, 82(3), 1998, pp. 635
NON-HEPARIN GLYCOSAMINOGLYCANS-INDUCED GENERATION OF ANTIPLATELET FACTOR-4 HEPARIN ANTIBODIES - IMPLICATIONS IN THE MANAGEMENT OF HIT SYNDROME
Authors: FAREED J HOPPENSTEADT DA JESKE W AMIRAL J WALENGA JM
Citation: J. Fareed et al., NON-HEPARIN GLYCOSAMINOGLYCANS-INDUCED GENERATION OF ANTIPLATELET FACTOR-4 HEPARIN ANTIBODIES - IMPLICATIONS IN THE MANAGEMENT OF HIT SYNDROME, Clinical chemistry, 44, 1998, pp. 212-212
DEVELOPMENT OF AN IMPROVED HPLC METHOD FOR THE QUANTITATION OF ARGATROBAN - APPLICATIONS IN THE STUDY OF PHARMACOKINETICS IN PATIENTS UNDERGOING CORONARY ANGIOPLASTY AND THERAPEUTIC ANTICOAGULATION
Authors: AHMAD S ASHAN A WALENGA JM FAREED J
Citation: S. Ahmad et al., DEVELOPMENT OF AN IMPROVED HPLC METHOD FOR THE QUANTITATION OF ARGATROBAN - APPLICATIONS IN THE STUDY OF PHARMACOKINETICS IN PATIENTS UNDERGOING CORONARY ANGIOPLASTY AND THERAPEUTIC ANTICOAGULATION, Clinical chemistry, 44, 1998, pp. 213-213
IMMUNOQUANTITATION OF SOLUBLE P-SELECTIN IN HUMAN PLASMA - EFFECT OF ANTICOAGULANT MATRIX AND PRELIMINARY CLINICAL-DATA
Authors: AMIN HM LIETZ H HOPPENSTEADT DA WALENGA JM GEORGE M AHMAD S FAREED J
Citation: Hm. Amin et al., IMMUNOQUANTITATION OF SOLUBLE P-SELECTIN IN HUMAN PLASMA - EFFECT OF ANTICOAGULANT MATRIX AND PRELIMINARY CLINICAL-DATA, Clinical chemistry, 44, 1998, pp. 223-223
PHARMACOKINETICS AND PHARMACODYNAMICS OF A SYNTHETIC ANTITHROMBIN AGENT, ARGATROBAN, IN MAN AS STUDIED BY HPLC AND FUNCTIONAL METHODS - IMPLICATIONS IN THE MONITORING AND DOSAGE-OPTIMIZATIONS IN CARDIOVASCULARPATIENTS
Authors: AHMAD S AHSAN A IQBAL O HOPPENSTEADT DA LEWIS BE WALENGA JM FAREED J
Citation: S. Ahmad et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF A SYNTHETIC ANTITHROMBIN AGENT, ARGATROBAN, IN MAN AS STUDIED BY HPLC AND FUNCTIONAL METHODS - IMPLICATIONS IN THE MONITORING AND DOSAGE-OPTIMIZATIONS IN CARDIOVASCULARPATIENTS, Clinical chemistry, 44, 1998, pp. 229-229
COMPARATIVE ANALYSES OF CIRCULATING ARGATROBAN LEVELS IN HEPARIN-INDUCED THROMBOCYTOPENIA PATIENTS UTILIZING HPLC AND ECARIN CLOTTING TIME METHODS
Authors: AHSAN A IQBAL O AHMAD S ANGELATS RS WALENGA JM FAREED J
Citation: A. Ahsan et al., COMPARATIVE ANALYSES OF CIRCULATING ARGATROBAN LEVELS IN HEPARIN-INDUCED THROMBOCYTOPENIA PATIENTS UTILIZING HPLC AND ECARIN CLOTTING TIME METHODS, Clinical chemistry, 44, 1998, pp. 230-230
MEASUREMENT OF PLATELET ACTIVATION IN HEPARIN-INDUCED THROMBOCYTOPENIA USING 3 COLOR-FLOW CYTOMETRY
Authors: JESKE W WOOD J SZATKOWSKI E BAKHOS M SHANKEY TV WALENGA JM
Citation: W. Jeske et al., MEASUREMENT OF PLATELET ACTIVATION IN HEPARIN-INDUCED THROMBOCYTOPENIA USING 3 COLOR-FLOW CYTOMETRY, Clinical chemistry, 44, 1998, pp. 232-232
OPTIMIZATION OF LABORATORY ASSAYS FOR THE DIAGNOSIS OF HEPARIN-INDUCED THROMBOCYTOPENIA
Authors: WOOD J JESKE W WALENGA JM
Citation: J. Wood et al., OPTIMIZATION OF LABORATORY ASSAYS FOR THE DIAGNOSIS OF HEPARIN-INDUCED THROMBOCYTOPENIA, Clinical chemistry, 44, 1998, pp. 237-237
EFFECT OF ANTIPLATELET AGENTS ON THE HEPARIN-INDUCED THROMBOCYTOPENICSERUM-INDUCED ACTIVATION OF PLATELETS AS MEASURED BY FLOW-CYTOMETRY
Authors: WALENGA JM JESKE W HAAS S MESSMORE HL BAKHOS M
Citation: Jm. Walenga et al., EFFECT OF ANTIPLATELET AGENTS ON THE HEPARIN-INDUCED THROMBOCYTOPENICSERUM-INDUCED ACTIVATION OF PLATELETS AS MEASURED BY FLOW-CYTOMETRY, Clinical chemistry, 44, 1998, pp. 238-238
PERSISTENCE OF THROMBOTIC COMPLICATIONS IN HEPARIN-INDUCED THROMBOCYTOPENIA PATIENTS AFTER HEPARIN WITHDRAWAL - PROPOSED MECHANISMS OF CONTINUED PLATELET ACTIVATION
Authors: WALENGA JM AHMAD S JESKE WP WOOD J AMIRAL J LEWIS BE
Citation: Jm. Walenga et al., PERSISTENCE OF THROMBOTIC COMPLICATIONS IN HEPARIN-INDUCED THROMBOCYTOPENIA PATIENTS AFTER HEPARIN WITHDRAWAL - PROPOSED MECHANISMS OF CONTINUED PLATELET ACTIVATION, Circulation, 98(17), 1998, pp. 4199-4199
LOW-MOLECULAR-WEIGHT HEPARINS - PHARMACOLOGICAL PROFILE AND PRODUCT DIFFERENTIATION
Authors: FAREED J JESKE W HOPPENSTEADT D CLARIZIO R WALENGA JM
Citation: J. Fareed et al., LOW-MOLECULAR-WEIGHT HEPARINS - PHARMACOLOGICAL PROFILE AND PRODUCT DIFFERENTIATION, The American journal of cardiology, 82(5B), 1998, pp. 3-10
DEVELOPMENT OF AN HPLC METHOD FOR THE QUANTITATION OF ARGATROBAN - APPLICATIONS IN THE STUDY OF PHARMACOKINETICS IN PATIENTS UNDERGOING CORONARY ANGIOPLASTY AND THERAPEUTIC ANTICOAGULATION
Authors: AHSAN A AHMAD S GEORGE M WALENGA JM SCHWARTZ R FAREED J
Citation: A. Ahsan et al., DEVELOPMENT OF AN HPLC METHOD FOR THE QUANTITATION OF ARGATROBAN - APPLICATIONS IN THE STUDY OF PHARMACOKINETICS IN PATIENTS UNDERGOING CORONARY ANGIOPLASTY AND THERAPEUTIC ANTICOAGULATION, The FASEB journal, 11(3), 1997, pp. 1828-1828
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>